Home > Publications Database > Seasonal variation in myasthenia gravis incidence. > print

001     275968
005     20250126000534.0
024 7 _ |a 10.1016/j.jneuroim.2025.578524
|2 doi
024 7 _ |a pmid:39799766
|2 pmid
024 7 _ |a 0165-5728
|2 ISSN
024 7 _ |a 1872-8421
|2 ISSN
024 7 _ |a altmetric:172906080
|2 altmetric
037 _ _ |a DZNE-2025-00164
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Falso, Silvia
|b 0
245 _ _ |a Seasonal variation in myasthenia gravis incidence.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737451789_5211
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Environmental factors may contribute to myasthenia gravis (MG) development, sometimes with seasonal patterns of exposure. However, whether seasonality has an impact on MG incidence remains unclear. We aimed to investigate the association between seasonality and MG onset.We reviewed data of MG patients with acetylcholine receptor (AChR)-IgG and disease onset between January 2010-December 2019, from two Italian cohorts: 1) an hospital-based cohort and 2) a population-based cohort. MG cases were assigned to four season-trimesters based on month of onset to determine seasonal association with MG incidence.We enrolled 316 patients:214 in the hospital-based and 102 in the population-based cohort. Median age at onset was 66 years (range, 8-92); Female accounted for 41.1 %. The median number of new MG cases per season-trimester was significantly higher in summer than other trimesters (p = 0.009), and associated with higher environmental temperatures.Our findings suggest that MG onset may be more common in summer and at higher environmental temperatures. Identifying the determinants of this association may improve our understanding of disease pathophysiology.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a AChR-IgG
|2 Other
650 _ 7 |a Epidemiology
|2 Other
650 _ 7 |a Onset
|2 Other
650 _ 7 |a Presentation
|2 Other
650 _ 7 |a Risk
|2 Other
700 1 _ |a Zara, Pietro
|b 1
700 1 _ |a Marini, Sofia
|b 2
700 1 _ |a Puci, Mariangela
|b 3
700 1 _ |a Sabatelli, Eleonora
|b 4
700 1 _ |a Sotgiu, Giovanni
|b 5
700 1 _ |a Marini, Martina
|b 6
700 1 _ |a Spagni, Gregorio
|0 P:(DE-2719)9002395
|b 7
|u dzne
700 1 _ |a Evoli, Amelia
|b 8
700 1 _ |a Solla, Paolo
|b 9
700 1 _ |a Iorio, Raffaele
|b 10
700 1 _ |a Sechi, Elia
|b 11
773 _ _ |a 10.1016/j.jneuroim.2025.578524
|g Vol. 399, p. 578524 -
|0 PERI:(DE-600)1500497-1
|p 578524
|t Journal of neuroimmunology
|v 399
|y 2025
|x 0165-5728
856 4 _ |u https://pub.dzne.de/record/275968/files/DZNE-2025-00164%20SUP.docx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/275968/files/DZNE-2025-00164.pdf
856 4 _ |u https://pub.dzne.de/record/275968/files/DZNE-2025-00164%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/275968/files/DZNE-2025-00164%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/275968/files/DZNE-2025-00164%20SUP.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/275968/files/DZNE-2025-00164.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:275968
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9002395
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROIMMUNOL : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-07
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1810003
|k AG Prüß
|l Autoimmune Encephalopathies
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1810003
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21